Epigenomic mapping and effect sizes of noncoding variants associated with psychotropic drug response

Pharmacogenomics

Volumn 16, Issue 14, 2015, Pages 1565-1573

  Higgins, Gerald A ^a,b   Allyn Feuer, Ari ^a   Athey, Brian D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Assurex Health Inc ^*  (United States)

Author keywords

chromatin spatial interactions; pharmacodynamics; pharmacogenomics; pharmacokinetics

Indexed keywords

COHESIN; DEOXYRIBONUCLEASE I; EXCITATORY AMINO ACID TRANSPORTER 2; PSYCHOTROPIC AGENT; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CTCF; CELL CYCLE PROTEIN; CHROMATIN; NONHISTONE PROTEIN;

ARTICLE; BIOINFORMATICS; BIPOLAR DISORDER; CHROMATIN STRUCTURE; CHRONICITY; DNA METHYLATION; DRUG RESPONSE; DRUG SAFETY; ENHANCER REGION; EPIGENETICS; GENE EXPRESSION REGULATION; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MOLECULAR INTERACTION; PHARMACOGENOMICS; PROMOTER REGION; PROTEIN BINDING; SINGLE NUCLEOTIDE POLYMORPHISM; SLC1A2 GENE; BIOLOGY; CAUCASIAN; CHROMATIN; CHROMOSOMAL MAPPING; COMPUTER SIMULATION; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; PROCEDURES;

CELL CYCLE PROTEINS; CHROMATIN; CHROMOSOMAL PROTEINS, NON-HISTONE; CHROMOSOME MAPPING; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DEOXYRIBONUCLEASE I; DNA METHYLATION; EPIGENOMICS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTROPIC DRUGS; TRANSCRIPTION FACTORS;

EID: 84945574605     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.15.105     Document Type: Article

References (124)

1. Zhou K, Pearson ER. Insights from genome-wide association studies of drug response. Annu. Rev. Pharmacol. Toxicol. 53, 299-310 (2013).
2. Meyer UA, Zanger UM, Schwab M. Omics and drug response. Annu. Rev. Pharmacol. Toxicol. 53, 475-502 (2013).
3. Fu W, O'Connor TD, Jun G et al. Analysis of 6, 515 exomes reveals the recent origin of most human protein-coding variants. Nature 493, 216-220 (2013).
4. Roussos P, Mitchell AC, Voloudakis G et al. A role for noncoding variation in schizophrenia. Cell Rep. 9, 1417-29 (2014).
5. Onengut-Gumuscu S, Chen W-G, Burren O et al. Fine mapping of Type 1 diabetes susceptibility loci and evidence for co-localization of causal variants with lymphoid gene enhancers. Nat. Genet. 47, 381-386 (2015).
6. Farh KK, Marson A, Zhu J et al. Genetic and epigenetic fne mapping of causal autoimmune disease variants. Nature. 518, 337-343 (2015).
7. Yao L, Tak YG, Berman BP, Farnham PJ. Functional annotation of colon cancer risk SNPs. Nat. Comm. 5, 5114 (2015).
8. Weinhold N, Jacobsen A, Schultz N, Sander C, Lee W. Genome-wide analysis of noncoding regulatory mutations in cancer. Nat. Genet. 46, 1160-1165 (2014).
9. Guenther CA, Tasic B, Luo L, Bedell MA, Kingsley DM. A molecular basis for classic blond hair color in Europeans. Nat. Genet. 46, 748-52 (2014)
10. Cooper GM, Shendure J. Needles in stacks of needles: fnding disease-causal variants in a wealth of genomic data. Nat. Rev. Genet. 12, 628-640 (2011).
11. Manolio TA. Genomewide association studies and assessment of the risk of disease. N. Engl. J. Med. 363, 166-176 (2010).
12. Maurano MT, Humbert R, Rynes E et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190-1195 (2012).
13. Musunuru K, Strong A, Frank-Kamenetsky M et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 466, 714-719 (2010).
14. Parker SCJ, Stitzel ML, Taylor DL et al. Chromatin stretch enhancer states drive cell-specifc gene regulation and harbor human disease risk variants. Proc. Natl Acad. Sci. USA 110, 17921-17926 (2013).
15. Mokry M, Middendorp S, Wiegerinck CL et al. Many infammatory bowel disease risk loci include regions that regulate gene expression in immune cells and the intestinal epithelium. Gastroenterology 146, 1040-1047 (2014).
16. Califano A, Butte AJ, Friend S et al. Leveraging models of cell regulation and GWAS data in integrative network-based association studies. Nat. Genet. 44, 841-847 (2012).
17. McGeachie MJ, Clemmer GL, Lasky-Su J et al. Joint GWAS Analysis: comparing similar GWAS at different genomic resolutions identifes novel pathway associations with six complex diseases. Genomics Data 2, 202-211 (2014).
18. Sullivan PF1, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat. Rev. Genet. 13, 537-551 (2012).
19. Cross-Disorder Group of the Psychiatric Genomics Consortium. Identifcation of risk loci with shared effects on fve major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371-1379 (2013).
20. Kellis M, Wold B, Snyder MP et al. Defning functional DNA elements in the human genome. Proc. Natl Acad. Sci. USA 111, 6131-6138 (2014).
21. Rao SSP, Huntley MH, Durand NC et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 159, 1665-1680 (2014).
22. Dixon JR, Selvaraj S, Yue F. Topological domains in mammalian genomes identifed by analysis of chromatin interactions. Nature 485, 376-380 (2012).
23. Merkenschlager M, Odom DT. CTCF and cohesin: linking gene regulatory elements with their targets. Cell 152, 1285-1297 (2013).
24. The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
25. Roadmap Epigenomics Consortium. Integrative analysis of 111 reference human epigenomes. Nature 518, 317-330 (2015).
26. Gross DS, Garrard W T. Nuclease hypersensitive sites in chromatin. Annu. Rev. Biochem. 57, 159-197 (1988).
27. Boyle AP, Hong EL, Hariharan M et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 22, 1790-1797 (2012).
28. Zhou X, Li1 D, Zhang B et al. Epigenomic annotation of genetic variants using the Roadmap Epigenome Browser. Nat. Biotechnol. 33, 345-346 (2015).
29. Selvaraj S, Dixon JR, Bansal V, Ren B. Whole-genome haplotype reconstruction using proximity-ligation and shotgun sequencing. Nat. Biotech. 31, 1111-1118 (2013).
30. Leung D, Jung I, Rajagopal N et al. Integrative analysis of haplotype-resolved epigenomes across human tissues. Nature 518, 350-354 (2015).
31. Hyman SE. Revitalizing psychiatric therapeutics. Neuropsychopharmacol. Rev. 39, 220-229 (2014).
32. Welter D1, MacArthur J, Morales J et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 42, D1001-D1006 (2014).
33. Li MJ, Wang LY, Xia Z, Sham PC, Wang J. GWAS3D: detecting human regulatory variants by integrative analysis of genome-wide associations, chromosome interactions and histone modifcations. Nucleic Acids Res. 41, W 150-W 158 (2013).
34. Li C1, Dong X1, Fan H et al. The 3DGD: a database of genome 3D structure. Bioinformatics 30, 1640-1642 (2014).
35. Lee I, Blom UM, Wang PI, Shim JE, Marcotte EM. Prioritizing candidate disease genes by network-based boosting of genome-wide association data. Genome Res. 21, 1109-1121 (2011).
36. Ernst E, Kellis M. Large-scale imputation of epigenomic datasets for systematic annotation of diverse human tissues. Nat. Biotechnol. 33, 364-376 (2015).
37. Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3000 shared controls. Nature 447, 661-678 (2007).
38. Zhou X, Maricque B, Xie M et al. The human epigenome browser at Washington University. Nat. Methods 8, 989-990 (2011).
39. Rosenbloom KR, Dreszer TR, Pheasant M et al. ENCODE whole-genome data in the UCSC genome browser. Nucleic Acids Res. 38, D620-D625 (2010).
40. Karolchik D, Barber GP, Casper J et al. The UCSC Genome Browser database: 2014 update. Nucleic Acids Res. 42, D764-D770 (2014).
41. Sunkin SM, Ng L, Lau C et al. Allen Brain Atlas: an integrated spatio-temporal portal for exploring the central nervous system. Nucleic Acids Res. 41, D996-D1008 (2013).
42. Lu Z. PubMed and beyond: a survey of web tools for searching biomedical literature. Database 2011, baq036 (2011).
43. Pomerantz J. Google Scholar and 100 percent availability of information. Info. Tech. Lib. 25, 52-56 (2013).
44. Cohen J. A power primer. Psychol. Bulletin. 112, 155-159 (1992)
45. Park JH, Wacholder S, Gail MH et al. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat. Genet. 42, 570-575 (2010).
46. Lange LA, Willer CJ, Rich SS. Recent developments in genome and exome-wide analysis of plasma lipids. Curr. Opin. Lipidol. 26, 96-102 (2015).
47. Kato N, Takeuchi F, Tabara Y. Meta-analysis of genome-wide association studies identifes common variants associated with blood pressure variation in east Asians. Nat Genet. 43, 531-538 (2011).
48. Gray KA, Daugherty LC, Gordon SM, Seal RL, Wright MW, Bruford EA. Genenames.org: the HGNC resources in 2013. Nucleic Acids Res. 41, D545-D552 (2012).
49. Sherry ST, Ward MH, Kholodov M et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308-311 (2001).
50. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 40, D930-D934 (2012).
51. Yang T P, Beazley C, Montgomery SB et al. Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies. Bioinformatics 26, 2474-2476 (2010).
52. Lonsdale J, Thomas J, Salvatore M et al. The Genotype-Tissue Expression (GTEx) project. Nature Genet. 45, 580-585 (2013).
53. Ernst J, Kellis M. ChromHMM: automating chromatin-state discovery and characterization. Nat. Methods 9, 215-216 (2012).
54. Zhang R, Lahens NF, Ballance HI et al. A circadian gene expression atlas in mammals: implications for biology and medicine. Proc. Natl Acad. Sci. USA 111, 16219-16224 (2014).
55. Willer CJ, Schmidt EM, Sengupta S et al. Discovery and refnement of loci associated with lipid Levels. Nat. Genet. 45, 1274-1283 (2013).
56. Package 'pwr'. https://cran.r-project.org
57. Flicek P, Amode MR, Barrell D et al. Ensembl 2014. Nucleic Acids Res. 42, D749-D755 (2013).
58. ClinicalTrials.gov. www.clinicaltrials.gov
59. Sulem P, Gudbjartsson DF, Geller F et al. Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption. Hum. Mol. Genet. 20, 2071-2077 (2011).
60. Amin N, Byrne E, Johnson J et al. Genome-wide association analysis of coffee drinking suggests association with C Y P1 A1/C Y P1 A 2 and NRCAM. Mol. Psychiatry 17, 1116-1129 (2012).
61. Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol. Ther. 138, 103-141 (2013).
62. Cornelis MC, Monda KL, Yu K et al. Genome-wide meta-analysis identifes regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genet. 7, e1002033 (2011).
63. Domschke K, Reif A. Behavioral genetics of affective and anxiety disorders. In: Behavioral Neurogenetics. Cryan JF, Reif A (Eds). Springer, Berlin, Heidelberg, Germany 463-502 (2012).
64. Kumasaka N, Aoki M, Okada Y et al. Haplotypes with copy number and single nucleotide polymorphisms in CYP2A6 locus are associated with smoking quantity in a Japanese population. PLoS ONE 7, e44507 (2012).
65. Su T, Bao Z, Zhang QY, Smith TJ, Hong JY, Ding X. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high effciency metabolic activation of a tobacco-specifc carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 60, 5074-5079 (2000).
66. Tobacco and Genetics Consortium. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet. 42, 441-447 (2010).
67. Hoft NR, Stitzel JA, Hutchison KE, Ehringe MA. CHRNB2 promoter region: association with subjective effects to nicotine and gene expression differences. Genes Brain Behav. 10, 176-185 (2011).
68. Timofeeva MN, McKay JD, Smith GD et al. Genetic polymorphisms in 15q25 and 19q13 loci, cotinine levels, and risk of lung cancer in EPIC. Cancer Epidemiol. Biomarkers Prev. 20, 2250-2261 (2011).
69. Enoch MA, Rosser AA, Zhou Z, Mash DC, Yuan Q, Goldman D. Expression of glutamatergic genes in healthy humans across 16 brain regions; altered expression in the hippocampus after chronic exposure to alcohol or cocaine. Genes Brain Behav. 13, 758-776 (2014).
70. Nelson EC, Lynskey MT, Heath AC et al. Association of OPRD1 polymorphisms with heroin dependence in a large case-control series. Addiction Biol. 19, 111-121 (2014).
71. Pandit S, Zhou Y, Shiue L et al. Genome-wide analysis reveals SR protein cooperation and competition in regulated splicing. Mol. Cell 50, 223-235 (2013).
72. Kertes DA, Kalsi G, Prescott CA et al. Neurotransmitter and neuromodulator genes associated with a history of depressive symptoms in individuals with alcohol dependence. Alcohol. Clin. Exp. Res. 35, 496-505 (2011).
73. Blum K, Fornari F, Downs BW et al. Genetic Addiction Risk Score (GARS): Testing for Polygenetic Predisposition and Risk to Reward Defciency Syndrome (RDS). InTech Open Access Publisher (2011).
74. Liu Z, Guo X, Jiang Y, Zhang H. NCK2 is signifcantly associated with opiates addiction in African-origin men. Scientifc World Journal. 2013, 748979 (2013).
75. Huroy S. Mechanisms of EphB2 mediated opiate-dependent tolerance and learning [MS thesis]. University of Toronto, ON, Canada (2012).
76. Baik I, Cho NH, Kim SH, Han BG, Shin C. Genome-wide association studies identify genetic loci related to alcohol consumption in Korean men. Am. J. Clin. Nutr. 93, 809-816 (2011).
77. Cederbaum AI. Alcohol metabolism. Clin. Liver Dis. 16, 667-685 (2012).
78. Duell EJ, Sala N, Travier N et al. Genetic variation in alcohol dehydrogenase (ADH1A, ADH1B, ADH1C, ADH7) and aldehyde dehydrogenase (ALDH2), alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Carcinogenesis 33, 361-367 (2012).
79. Lind PA, Zhu G, Montgomery GW et al. Genome-wide association study of a quantitative disordered gambling trait. Addiction Biol. 18, 511-522 (2013).
80. Razvodovsky Y, Borodinsky A, Pascual-Mora M et al. Basic research. Alcohol and Alcoholism, 48(Suppl. 1), i41-i46 (2013).
81. Jagannathan L, Swaminathan K, Kumar SM, Kumar GR, Dey A. Bio-informatics based analysis of genes implicated in alcohol mediated liver injury. Gene 494, 130-139 (2012).
82. Wang C, Xu Y, Feng X et al. Linkage analysis and whole-exome sequencing exclude extra mutations responsible for the parkinsonian phenotype of spinocerebellar ataxia-2. Neurobiol. Aging 36, 545.e1-e7 (2015).
83. Modig F, Patel M, Magnusson M, Fransson PA. Study II: mechanoreceptive sensation is of increased importance for human postural control under alcohol intoxication. Gait Posture 35, 419-427 (2012).
84. Zuko A, Kleijer K T, Oguro-Ando A et al. Contactins in the neurobiology of autism. Eur. J. Pharmacol. 719, 63-74 (2013).
85. Verpelli C, Galimberti I, Gomez-Mancilla B, Sala C. Molecular basis for prospective pharmacological treatment strategies in intellectual disability syndromes. Dev. Neurobiol. 74, 197-206 (2014).
86. Mitchell KJ. The genetics of neurodevelopmental disease. Curr. Opin. Neurobiol. 21, 197-203 (2012).
87. Berezin V, Walmod PS. Cell Adhesion Molecules: Implications in Neurological Diseases. Vol. 8. Springer Science & Business Media, NY, USA (2013).
88. Mehta D, Klengel T, Conneely KN et al. Childhood maltreatment is associated with distinct genomic and epigenetic profles in posttraumatic stress disorder. Proc. Natl Acad. Sci. USA 110, 8302-8307 (2013)
89. Mullins N, Perroud N, Uher R et al. Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study. Am. J. Med. Genet. 165(5), 428-437 (2014).
90. Gelernter J, Kranzler HR, Sherva R et al. Genome-wide association study of nicotine dependence in american populations: identifcation of novel risk loci in both African-Americans and European-Americans. Biol. Psychiatry 77(5), 493-503 (2014).
91. Dallaspezia S, Poletti S, Lorenzi C, Pirovano A, Colombo C, Benedetti F. Influence of an interaction between lithium salts and a functional polymorphism in SLC1A2 on the history of illness in bipolar disorder. Mol. Diagn. Ther. 16, 303-309 (2012).
92. Djurovic S, Gustafssonc O, Mattingsdala M et al. A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample. J. Affect. Disord. 126, 312-316 (2010).
93. Thier S, Lorenz D, Nothnagel M et al. Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremor. Neurology 79, 243-248 (2012).
94. Aberg K, Adkins DE, Liu Y et al. Genome-wide association study of antipsychotic-induced QTc interval prolongation. Pharmacogenomics 12, 165-72 (2012).
95. Ostrousky O, Meged S, Loewenthal R et al. NQO2 gene is associated with clozapine-induced agranulocytosis. Tissue Antigens 62, 483-491 (2003).
96. Miettinen TP, Björklund M. NQO2 is a reactive oxygen species generating off-target for acetaminophen. Mol. Pharm. 11, 4395-4404 (2014).
97. Chang KC, Sasano T, Wang YC, Huang SKS. Nitric oxide synthase 1 adaptor protein, an emerging new genetic marker for QT prolongation and sudden cardiac death. Acta Cardiol. Sin. 29, 217-225 (2013).
98. Jamshidi Y, Nolte IM, Dalageorgou C et al. Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia. J. Am. Coll. Cardiol. 60, 841-850 (2012).
99. Kapoor A, Sekar RB, Hansen NF et al. QT Interval-International GWAS Consortium: an enhancer polymorphism at the cardiomyocyte intercalated disc protein NOS1AP locus is a major regulator of the QT interval. Am. J. Hum. Genet. 94, 854-869 (2014).
100. Tomás M, Napolitano C, De Giuli L et al. Priori Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome. J. Am. Coll. Cardiol. 55, 2745-2752 (2010).
101. Adkins DE, Åberg K, McClay JL et al. Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. Mol. Psychiatry 16, 321-332 (2011).
102. Kolder IC. Family-based genome-wide association analysis for the identifcation of genetic modifers of heart rate and electrocardiographic indices of conduction and repolarization in a large Dutch family with a mutation in SCN5A. Genetic modifers in familial cardiac rhythm disorders, 105 (2012).
103. Libbrecht MW, Ay F, Hoffman MM, Gilbert DM, Bilmes JA, Noble WS. Joint annotation of chromatin state and chromatin conformation reveals relationships among domain types and identifes domains of cell-type-specifc expression. Genome Res. 25, 1-14 (2015).
104. Hoffman MM, Buske OJ, Wang J, Weng Z, Bilmes JA, Noble WS. Unsupervised pattern discovery in human chromatin structure through genomic segmentation. Nat. Methods 9, 473-476 (2012).
105. Zanger UM, Klein K, Thomas M et al. Genetics, epigenetics and regulation of drug metabolizing cytochrome P450 enzymes. Clin. Pharmacol. Ther. 95, 258-261 (2014).
106. Schaub MA, Boyle AP, Kundaje A, Batzoglou S, Snyder M. Linking disease associations with regulatory information in the human genome. Genome Res. 22, 1748-1759 (2012).
107. Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 489, 391-399 (2012).
108. Kang HJ, Kawasawa YI, Cheng F et al. Spatio-temporal transcriptome of the human brain. Nature 478, 483-489 (2011).
109. Aguilar-Arnal L, Sassone-Corsi P. Chromatin landscape and circadian dynamics: Spatial and temporal organization of clock transcription. Proc. Natl Acad. Sci. USA 112, 6863-6870 (2014).
110. Borel C, Ferreira PG, Santoni F et al. Biased allelic expression in human primary fbroblast single cells. Am. J. Hum. Genet. 96, 1-11 (2015).
111. Deng Q, Ramskold D, Reinius B et al. Single-cell RNA-seq reveals dynamic, random mono-allelic gene expression in mammalian cells. Science 343, 193-196 (2014).
112. Osborne CS, Chakalova L, Brown KE et al. Active genes dynamically co-localize to shared sites of ongoing transcription. Nat. Genet. 36, 1065-1071 (2004).
113. Palacios R, Gazave E, Goñi J et al. Allele-specifc gene expression is widespread across the genome and biological processes. PLoS ONE 4, e4150 (2009).
114. Schalkwyk LC, Meaburn EL, Smith R et al. Allelic skewing of DNA methylation is widespread across the genome. Am. J. Hum. Genet. 86, 196-212 (2010).
115. McDaniell R, Lee BK, Song L et al. Heritable individual-specifc and allele-specifc chromatin signatures in humans. Science 328, 235-239 (2010).
116. Park J, Gail MH, Weinberg CR et al. Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants. Proc. Natl Acad. Sci. USA 108, 18026-18031 (2011).
117. Stringer S, Wray NR, Kahn RS, Derks EM. Underestimated effect sizes in GWAS: fundamental limitations of single SNP analysis for dichotomous phenotypes. PLoS ONE 6, e27964 (2011).
118. Brownstein MJ. A brief history of opiates, opioid peptides, and opioid receptors. Proc. Natl Acad. Sci. USA 90, 5391-5393 (1993).
119. Crocq M. Historical and cultural aspects of man's relationship with addictive drugs. Dialogues Clin Neurosci. 9, 355-361 (2007).
120. Edwards SL, Beesley J, French JD, Dunning M. Beyond GWAS: illuminating the dark road from association to function. Am. J. Hum. Genet. 93, 779-797 (2013).
121. Benjamini Y, Hochberg B. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Royal Stat. Soc. 57(1), 289-300 (1995).
122. Lee SH, Yang J, Goddard ME, Visscher PM, Wray NR. Estimation of pleiotropy between complex diseases using single-nucleotide polymorphism-derived genomic relationships and restricted maximum likelihood. Bioinformatics 28, 2540-2542 (2012).
123. Jia P, Wang L, Meltzer HY, Zhaoa Z. Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data. Schizophr. Res. 122, 38-42 (2010).
124. Shi G, Boerwinkle E, Morrison AC, Gu CC, Chakravarti A, Rao DC. Mining gold dust under the genome wide signifcance level: a two-stage approach to analysis of GWAS. Genet. Epidemiol. 35, 111-118 (2011).